However, recently it has also been shown that the increase of intracellular acidity in activated T cells due to the lack of Hv1 proton channel reduces the effector function of T cells [31], which must also be considered to determine the overall outcome of Hv1-targeted cancer therapy. This evidence concerns the gene HVCN1 and cancer.